These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 7107360

  • 1. Azomycin riboside: a new radiosensitizer.
    Pedersen JE, Barron G, Chapman JD.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [Abstract] [Full Text] [Related]

  • 2. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K, Shibamoto Y, Takahashi M, Abe M, Wang J, Zhou L, Nishimoto S, Kagiya T.
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [Abstract] [Full Text] [Related]

  • 3. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC, Rupp WD, Rockwell S.
    Radiat Res; 1986 Feb; 105(2):227-39. PubMed ID: 3754053
    [Abstract] [Full Text] [Related]

  • 4. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
    Sasai K, Shibamoto Y, Takahashi M, Zhou L, Hori H, Nagasawa H, Shibata T, Inayama S, Abe M.
    Cancer Chemother Pharmacol; 1990 Feb; 26(2):112-6. PubMed ID: 2140730
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM, Dionet C, Brown JM.
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [Abstract] [Full Text] [Related]

  • 6. Clinical trials of radiosensitizers: what should we expect?
    Brown JM.
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [Abstract] [Full Text] [Related]

  • 7. Iodoazomycin riboside (1-(5'-iodo-5'-deoxyribofuranosyl)-2-nitroimidazole), a hypoxic cell marker. I. Synthesis and in vitro characterization.
    Jette DC, Wiebe LI, Flanagan RJ, Lee J, Chapman JD.
    Radiat Res; 1986 Feb; 105(2):169-79. PubMed ID: 3952269
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM, Yu NY, Brown JM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1982 Feb; 8(3-4):435-8. PubMed ID: 7107364
    [Abstract] [Full Text] [Related]

  • 9. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T, Nakajima T, Onoyama Y, Murayama C, Mori T, Nagasawa H, Hori H, Inayama S.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):601-5. PubMed ID: 8005823
    [Abstract] [Full Text] [Related]

  • 10. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
    Shibamoto Y, Sakano K, Kimura R, Nishidai T, Nishimoto S, Ono K, Kagiya T, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1063-6. PubMed ID: 3744928
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C, Suzuki A, Suzuki T, Miyata Y, Sakaguchi M, Tanabe Y, Tanaka N, Mori T.
    Int J Radiat Oncol Biol Phys; 1989 Sep 15; 17(3):575-81. PubMed ID: 2528527
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
    Shibamoto Y, Sasai K, Sakaguchi M, Tamulevicius P, Kitakabu Y, Streffer C, Abe M.
    Int J Radiat Biol; 1991 Jan 15; 59(1):105-15. PubMed ID: 1671058
    [Abstract] [Full Text] [Related]

  • 13. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I, Guttman P.
    Int J Radiat Oncol Biol Phys; 1982 Jan 15; 8(3-4):663-6. PubMed ID: 7107395
    [Abstract] [Full Text] [Related]

  • 14. [Recent advances in hypoxic cell radiosensitizer].
    Ono K, Takahashi M, Nishidai T, Shibamoto Y, Abe M.
    Gan No Rinsho; 1983 Oct 15; 29(13):1608-12. PubMed ID: 6230470
    [Abstract] [Full Text] [Related]

  • 15. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D, Peacock JH, Stephens TC.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):643-6. PubMed ID: 7107390
    [Abstract] [Full Text] [Related]

  • 17. DNA-targeted 2-nitroimidazoles: studies of the influence of the phenanthridine-linked nitroimidazoles, 2-NLP-3 and 2-NLP-4, on DNA damage induced by ionizing radiation.
    Buchko GW, Weinfeld M.
    Radiat Res; 2002 Sep 15; 158(3):302-10. PubMed ID: 12175307
    [Abstract] [Full Text] [Related]

  • 18. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B, Faddegon B, Skarsgard LD.
    Radiat Res; 1984 Nov 15; 100(2):340-7. PubMed ID: 6494445
    [Abstract] [Full Text] [Related]

  • 19. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA, Hall EJ.
    Br J Cancer; 1981 Aug 15; 44(2):201-7. PubMed ID: 6168277
    [Abstract] [Full Text] [Related]

  • 20. Chromosome-damaging activity of a ruthenium radiosensitizer, RuCl2 (DMSO)2 (4-nitroimidazole)2, in Chinese hamster ovary cells in vitro.
    Chan PK, Skov KA, James BR, Farrell NP.
    Chem Biol Interact; 1986 Oct 01; 59(3):247-54. PubMed ID: 3769054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.